Main > > >SOLID TUMORS. *

---

TREAT.: Entrectinib Capsules.
[Harboring an NTRK (Neuro Trophic Recep- tor tyrosine Kinase) Gene Fusion].
Companion DIAG.>Launch Date: 2019. 11.21
JP Approval Date : 2019. 06.18.
USA Approval Date: 2019. 08.15.
(*) Companies; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 01.12.




TREAT.: High Dose ChemoTherapy+Haemato-poietic Progenitor Cell Transplantation (HPCT)+Alkylating agent Thiotepa
Approved in CH; EU; HK; IL; IN & RU.
(*) Company : Adienne
Patent : Expired
TradeMark: Tepadina
Web-Site :
www.adienne.com/?page_id=1248
UpDate: 2019. 11.12




TREAT.: Larotrectinib.
[Harboring an NTRK (Neuro Trophic Recep- tor tyrosine Kinase) Gene Fusion].
Companion DIAG.>Liquid Biopsy>
>Launch Date: 2019. 11.21.
Companion DIAG.>Tissue Based>
>USA Approval Date: 2020. 10.23.
CA Approval Date : 2019. 07.30.
USA Approval Date : 2018. 11.27.
(*) Companies; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2021. 02.11.




TREAT.: PembrolizuMAb Inj.
(TMB-H>10 UnResectable or METASTATIC)
USA Approval Date: 2020. 06.17.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.30.


>SOLID TUMORS. *'s products
This section has no products